BACKGROUND. The incidence of pertussis is increasing, especially in adolescents,
attributed in part to waning of immunity after childhood immunization. Recently licensed in …

Objective. To compare the immunogenicity and reactogenicity of a diphtheria and tetanus
toxoids and three-component acellular pertussis vaccine (DTaP) with a diphtheria and …

Objective. To compare the safety and immunogenicity of 12 different acellular pertussis
vaccines combined with diphtheria and tetanus toxoids (DTaP) with one licensed diphtheria …

Acellular pertussis vaccines combined with diphtheria and tetanus toxoids have proven to
be well tolerated, immunogenic and effective in reducing pertussis disease in adolescents …

Objective. To evaluate the safety and immunogenicity of 6 different acellular pertussis
vaccines combined with diphtheria and tetanus toxoids (DTaP) and with 1 licensed whole …

Background: The epidemiology of pertussis is changing, with a clear increase in the number
of cases diagnosed in adolescents and adults. This development has spurred studies and …

This Policy Statement was retired June 2012. The purpose of this statement is to provide the
rationale and recommendations for adolescent use of tetanus toxoid, reduced diphtheria …

Objective. To compare the safety and immunogenicity of a variety of acellular (AC) and
whole-cell (WC) pertussis vaccines combined with diphtheria and tetanus toxoids. Methods …

OBJECTIVES: To determine pertussis risk by diphtheria-tetanus-acellular pertussis (DTaP)
vaccination status and time since last DTaP dose. METHODS: Children born at Kaiser …

Importance There is accumulating literature on waning acellular pertussis vaccine–induced
immunity, confirming the results of studies assessing the duration of protection of pertussis …